Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging Treatment Options in Inflammatory Bowel Disease: Janus Kinases, Stem Cells, and More
Benjamin Misselwitz, Pascal Juillerat, Michael Christian Sulz, et al.
Digestion (2020) Vol. 101, Iss. Suppl. 1, pp. 69-82
Open Access | Times Cited: 66

Showing 26-50 of 66 citing articles:

Effects of Allogeneic Mesenchymal Stem Cell Transplantation in Dogs with Inflammatory Bowel Disease Treated with and without Corticosteroids
José Ignacio Cristóbal, Francisco Javier Duque, Jesús M. Usón‐Casaús, et al.
Animals (2021) Vol. 11, Iss. 7, pp. 2061-2061
Open Access | Times Cited: 20
Current Therapy in Inflammatory Bowel Disease: Why and How We Need to Change?
Katherine Falloon, Claudio Fiocchi
EMJ Innovation (2022), pp. 40-49
Open Access | Times Cited: 14
Biological Treatments in Inflammatory Bowel Disease: A Complex Mix of Mechanisms and Actions
Lorena Ortega Moreno, Samuel Fernández‐Tomé, Raquel Abalo
Biologics (2021) Vol. 1, Iss. 2, pp. 189-210
Open Access | Times Cited: 18
Comparative Analysis of Inflammatory Bowel Disease Management
Ariel Israel, Κassem Sharif, Galit Zada, et al.
Journal of Clinical Gastroenterology (2024)
Closed Access | Times Cited: 2
A Review of the Efficacy and Safety for Biologic Agents Targeting IL-23 in Treating Psoriasis With the Focus on Tildrakizumab
Feras M. Ghazawi, Farhan Mahmood, Leon Kircik, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 14
Cellular and molecular mediators of lymphangiogenesis in inflammatory bowel disease
Dickson Kofi Wiredu Ocansey, Bing Pei, Xinwei Xu, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 13
Effects of Immune Cells on Intestinal Stem Cells: Prospects for Therapeutic Targets
Liyun Ma, Jianghong Yu, Huilu Zhang, et al.
Stem Cell Reviews and Reports (2022) Vol. 18, Iss. 7, pp. 2296-2314
Closed Access | Times Cited: 10
Medically Refractory Lymphocytic Colitis Successfully Treated With Upadacitinib
Yusuke Miyatani, David Choi, Xiaotang Du, et al.
ACG Case Reports Journal (2023) Vol. 10, Iss. 2, pp. e00979-e00979
Open Access | Times Cited: 5
Role of CD34 in inflammatory bowel disease
Zhiyuan Li, Shuyan Dong, Shichen Huang, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 5
Novel Therapies for Patients With Inflammatory Bowel Disease.
Priscila Santiago, Manuel B. Braga Neto, Edward V. Loftus
PubMed (2022) Vol. 18, Iss. 8, pp. 453-465
Closed Access | Times Cited: 9
Paenibacillus exopolysaccharide repairs GI inflammation by suppressing MAPK and NF-κB and restoring lipid production in Caco-2 cell line
Jing Zhang, LI Zhi-qiang, Ru-Jing Zheng, et al.
Journal of Functional Foods (2023) Vol. 107, pp. 105709-105709
Open Access | Times Cited: 4
Choosing the right biologic for complications of inflammatory bowel disease
Shana Rakowsky, Konstantinos Papamichael, Adam S. Cheifetz
Expert Review of Gastroenterology & Hepatology (2022) Vol. 16, Iss. 3, pp. 235-249
Closed Access | Times Cited: 7
Effectiveness of golimumab in patients with ulcerative colitis: results of a real-life study in Switzerland
Kathrin Perrig, Niklas Krupka, Sebastian Bruno Ulrich Jordi, et al.
Therapeutic Advances in Gastroenterology (2022) Vol. 15
Open Access | Times Cited: 7
Mechanotransduction through adhesion molecules: Emerging roles in regulating the stem cell niche
Ryan G. Lim, Avinanda Banerjee, Ritusree Biswas, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 7
Strategies to improve the effect of mesenchymal stem cell therapy on inflammatory bowel disease
Meng-Yue Shi, Lian Liu, Fuyuan Yang
World Journal of Stem Cells (2022) Vol. 14, Iss. 9, pp. 684-699
Open Access | Times Cited: 7
SARS-CoV-2 vaccination in inflammatory bowel disease patients is not associated with flares: a retrospective single-centre Swiss study
Laura Rossier, Natalie Décosterd, Christoph Matter, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 1
The diverse roles of sphingolipids in inflammatory bowel disease
Chelsea L. Doll, Ashley J. Snider
The FASEB Journal (2024) Vol. 38, Iss. 13
Closed Access | Times Cited: 1
From promise to practice: CAR T and Treg cell therapies in autoimmunity and other immune-mediated diseases
Yannick Bulliard, Robert A. Freeborn, Molly Javier Uyeda, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Serum inter-alpha-trypsin inhibitor heavy chain 4 in patients with inflammatory bowel disease: correlation with disease risk, inflammation, activity, and its variation after treatment
Wen Nuan, Na Zhao, Huixian Xu, et al.
Irish Journal of Medical Science (1971 -) (2021) Vol. 191, Iss. 5, pp. 2105-2111
Closed Access | Times Cited: 9
Correlation Between Crohn's Disease Activity and Serum Selenium Concentration
Yan Wu, Wei Meihao, Zihan Song, et al.
Clinical Therapeutics (2022) Vol. 44, Iss. 5, pp. 736-743.e3
Closed Access | Times Cited: 6
Aspects Towards the Anastomotic Healing in Crohn’s Disease: Clinical Approach and Current Gaps in Research
Fábio Henrique Mendonça Chaim, Leandro Minatel Vidal de Negreiros, Karine Mariane Steigleder, et al.
Frontiers in Surgery (2022) Vol. 9
Open Access | Times Cited: 6
Hit the Road JAK! The Role of New Oral Treatment in Inflammatory Bowel Disease
Isabel Garrido, Susana Lopes, Guilherme Macedo
Inflammatory Bowel Diseases (2021) Vol. 27, Iss. 12, pp. 2010-2022
Closed Access | Times Cited: 7
Conventional treatment and new drugs
Lívia Moreira Genaro, Julian Furtado Silva, Luís Eduardo Miani Gomes, et al.
Elsevier eBooks (2023), pp. 47-69
Closed Access | Times Cited: 2
Signaling Pathways and Molecular Process of Natural Polyphenols in the Amelioration of Inflammatory Bowel Disease: A Privileged Scaffold in New Drug Discovery
Om Prakash, Ruchi Singh, Priyanka Bajpai, et al.
Current Drug Research Reviews (2023) Vol. 16, Iss. 1, pp. 57-72
Closed Access | Times Cited: 2
Evaluation of Anti-Inflammatory Effect of Wedelolactone on Indomethacin Induced Colitis in Rats: Involvement of IL-6/STAT3 Pathway
Prakash Tigari, Suresh Janadri, Krishnadas Madhu, et al.
Biointerface Research in Applied Chemistry (2021) Vol. 12, Iss. 3, pp. 2813-2825
Open Access | Times Cited: 4

Scroll to top